Odelle Technology is a specialist consulting firm that helps innovative health technologies secure reimbursement, regulatory alignment, and clinical adoption across the UK, EU, and US. We work with MedTech, in vitro diagnostics (IVD), digital health apps, AI-based platforms, and therapeutic developers to design evidence-based pathways for market access. This service spans from early-stage strategic planning through to real-world implementation. We support health technology assessments (HTAs), pricing dossiers, and regional funding applications, including PECAN and Article 51 in France, DiGA and NUB in Germany, and NICE or NHS Innovation pathways in the UK. We specialise in identifying the right clinical and economic evidence to satisfy payers, regulators, and procurement bodies. This includes cost-consequence modelling, pilot study design, stakeholder engagement, and comparator mapping. Whether your technology is CE-marked, FDA-cleared, or still in development, we tailor our approach to your maturity stage and target markets. Odelle’s senior team has over 100 years of combined experience in scientific, economic, and regulatory strategy, ensuring your innovation can demonstrate value, achieve coverage, and reach patients faster.